Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT S Akhtar, AS Al-Sugair, M Abouzied, Y Alkadhi, M Dingle, M Abdelsalam, ... Bone marrow transplantation 48 (12), 1530-1536, 2013 | 62 | 2013 |
Pure dysgerminoma of the ovary: a single institutional experience of 65 patients H Al Husaini, H Soudy, AED Darwish, M Ahmed, A Eltigani, ... Medical Oncology 29, 2944-2948, 2012 | 56 | 2012 |
Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience H Al-Husaini, H Soudy, A Darwish, M Ahmed, A Eltigani, W Edesa, ... Clinical and Translational Oncology 17, 409-415, 2015 | 25 | 2015 |
CD3+ T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma N Al-Rajhi, H Soudy, SA Ahmed, T Elhassan, SF Mohammed, HA Khoja, ... BMC cancer 20, 1-13, 2020 | 24 | 2020 |
Awareness and perceptions of clinical trials in cancer patients and their families in Saudi Arabia S Bazarbashi, A Hassan, AM Eldin, H Soudy, F Hussain Journal of Cancer Education 30, 655-659, 2015 | 24 | 2015 |
Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination Y Huang, NA Alzahrani, W Liauw, H Soudy, AM Alzahrani, DL Morris European Journal of Surgical Oncology 43 (12), 2292-2298, 2017 | 23 | 2017 |
Co‐administration of intravesical bacillus Calmette‐Guérin and interferon α‐2B as first line in treating superficial transitional cell carcinoma of the urinary bladdera S Bazarbashi, H Soudy, M Abdelsalam, A Al‐Jubran, S Akhtar, M Memon, ... BJU international 108 (7), 1115-1118, 2011 | 22 | 2011 |
Unchecked immunity: a unique case of sequential immune-related adverse events with pembrolizumab N Shah, J Jacob, Z Househ, E Shiner, L Baird, H Soudy Journal for ImmunoTherapy of Cancer 7, 1-6, 2019 | 21 | 2019 |
Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer S Bazarbashi, A Aljubran, A Alzahrani, A Mohieldin, H Soudy, M Shoukri Cancer medicine 4 (10), 1505-1513, 2015 | 18 | 2015 |
A modern regimen of pre‐operative concurrent chemo‐radiation therapy in locally advanced rectal cancer S Bazarbashi, M el‐Bassiouni, M Abdelsalam, H Soudy, N Sanea, ... Journal of Surgical Oncology 98 (3), 167-174, 2008 | 18 | 2008 |
Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) version 4 quality of life instrument into Arabic language H Soudy, I Maghfoor, TAM Elhassan, E Abdullah, SM Rauf, A Al Zahrani, ... Health and Quality of life Outcomes 16, 1-10, 2018 | 15 | 2018 |
Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 years S Akhtar, I Youssef, H Soudy, TAM Elhassan, SM Rauf, I Maghfoor Bone Marrow Transplantation 50 (12), 1551-1556, 2015 | 14 | 2015 |
Pre-transplant 18F-fluorodeoxyglucose positron emission tomography-based survival model in patients with aggressive lymphoma undergoing high-dose chemotherapy and autologous SCT S Akhtar, AS Al-Sugair, M Abouzied, Y Alkadhi, M Dingle, M Abdelsalam, ... Bone marrow transplantation 48 (4), 551-556, 2013 | 13 | 2013 |
Pre-operative chemoradiotherapy using capecitabine and cetuximab followed by definitive surgery in patients with operable rectal cancer S Bazarbashi, A Omar, A Aljubran, A Alzahrani, N Alsanea, A Abduljabbar, ... Hematology/Oncology and Stem Cell Therapy 9 (4), 147-153, 2016 | 12 | 2016 |
Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus S Bazarbashi, M Abdelsalam, T Amin, M El-Bassiouni, H Soudy, ... Chemotherapy 54 (4), 315-322, 2008 | 11 | 2008 |
Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report J Chen, H Soudy Chinese Clinical Oncology 8 (3), 29-29, 2019 | 10 | 2019 |
Whole body 18F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial M Abdelsalam, S Bazarbashi, M Abouzied, T Amin, H Soudy, M Rahal, ... Hematology/Oncology and Stem Cell Therapy 3 (4), 179-184, 2010 | 10 | 2010 |
Adult-type ovarian granulosa cell tumour: treatment outcomes from a single-institution experience H Alhusaini, MA Elshenawy, A Badran, A Elshentenawy, A Mohieldin, ... Cureus 14 (11), 2022 | 5 | 2022 |
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: A case series and review DH Wai Siu, RS O'Neill, CA Harris, J Wang, L Ardolino, T Downton, ... Immunotherapy 14 (7), 511-520, 2022 | 5 | 2022 |
Low-dose fractionated radiation with induction docetaxel and cisplatin followed by concurrent cisplatin and radiation therapy in locally advanced nasopharyngeal cancer: a … NM Al-Rajhi, EM Khalil, S Ahmad, H Soudy, M AlGhazi, DM Fatani, ... Hematology/Oncology and Stem Cell Therapy 14 (3), 199-205, 2021 | 3 | 2021 |